Related Experiment Videos

Effects of a multifaceted educational program on blood pressure and cardiovascular risk in hypertensive patients: the

Sabine Perl1, Vesna Riegelnik, Peter Mrak

  • 1Division of Cardiology, Department of Internal Medicine, Medical University of Graz, Graz, Austria. sabine.perl@medunigraz.at

Journal of Hypertension
|August 23, 2011
PubMed

Insights

A structured educational program significantly improved blood pressure control and reduced cardiovascular risk in hypertensive patients. This multifaceted approach enhances patient care and outcomes.

Area of Science:

  • Cardiology
  • Public Health
  • Health Services Research

Background:

  • Hypertension is a leading risk factor for cardiovascular and cerebrovascular diseases.
  • Poor blood pressure control remains a significant challenge in patient management.
  • Multifaceted programs are needed to improve the quality of care for hypertensive patients.

Purpose of the Study:

  • To evaluate the effectiveness of a structured, multifaceted educational program for hypertensive patients.
  • To improve blood pressure control and reduce overall cardiovascular risk.
  • To assess the impact of structured documentation and peer comparison on care quality.

Main Methods:

  • A multicentre program involving structured educational sessions for patients and staff.
  • Inclusion criteria: uncontrolled office blood pressure and elevated cardiovascular risk (New Zealand Risk Score >15%).
  • Data collection included blood pressure, lipid panels, and cardiovascular risk assessment at baseline and 12-month follow-up.

Main Results:

  • Over 2000 patients were enrolled; 744 completed 1-year follow-up.
  • Mean blood pressure decreased significantly from 156.1/88.9 mmHg to 139.2/82.1 mmHg (P < 0.001).
  • Cardiovascular risk (NZRS) and BMI also showed significant improvements.

Conclusions:

  • The structured educational program effectively improved intermediate outcomes in hypertensive patients.
  • Significant reductions in blood pressure and individual cardiovascular risk profiles were achieved.
  • Broad implementation of this program is recommended for hypertension management.
Abstract

Related Concept Videos

Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...